MRNA Vaccines and Therapeutics Market Size is Surpassing 13% CAGR Growth by 2026

Report Overview:

The following report titled “Global MRNA Vaccines and Therapeutics Market: By mRNA Type (Nucleoside-Modified mRNA (modRNA), Unmodified mRNA, Self-Amplifying mRNA), By Application Type (COVID mRNA Application [Commercialised Vaccine {mRNA-1273, BNT162b2}, Pipeline Vaccines {CVnCoV, LUNAR-COV19, MRT5500, DS-5670}] Non-COVID mRNA Application [Immuno-Oncology, Cardiology, Endocrinology, Haematology, Other infectious & rare diseases]) and other forecast 2021-2026” provides a comprehensive analysis of the market, focusing on key details such as market size, growth trends, determinants of growth, segments covered, and the role of leading players in the industry.

Global MRNA Vaccines and Therapeutics Market Summary

The “Global mRNA Vaccines and Therapeutics Market” is likely to grow at a CAGR of around 13% during the forecast period, i.e., 2021-26, says MarkNtel Advisors. The market growth essentially attributes to the rising prevalence of infectious and chronic diseases, including HIV, diabetes, cancer, and cardiovascular diseases.

Additionally, the inability of the traditional vaccine approaches to perform at a critical time boosts the market growth. Further, technological advancements support the growth of the market as mRNA vaccines and therapeutics are developed with the help of advanced technologies so that these vaccines are highly effective in crucial times..

Report Coverage & Details

Forecast Period: 2021-2026
Base Year: 2020
CAGR: 13%

“In case you missed it, we are currently revising our reports. Click on the below to get the most latest research data with forecast for years 2024 to 2030, including market size, industry trends, and competitive analysis. It wouldn't take long for the team to deliver the most recent version of the report.”

Download Free PDF Brochure: - https://www.marknteladvisors.com/query/request-sample/global-mrna-vaccines-and-therapeutics-market.html

MRNA Vaccines and Therapeutics Market Driver:

mRNA vaccines help protect against various infectious diseases. The COVID-19 mRNA vaccines teach the cells to make a harmless piece of the spike protein. The spike protein lies on the surface of the COVID-19 virus. Once the mRNA vaccine gets injected, the body starts triggering an immune response, thereby creating antibodies against the virus. Moreover, mRNA vaccines are highly effective in combatting new variants of the COVID-19 virus. Hence, the increasing number of COVID-19 patients leads to accelerate the demand for mRNA vaccines and therapeutics.

Segmentation Analysis: MRNA Vaccines and Therapeutics Market

By mRNA Type

Nucleoside-Modified mRNA (modRNA)
Unmodified mRNA
Self-Amplifying mRNA

By Application Type

COVID mRNA Application
- Commercialised Vaccine
  - mRNA-1273
  - BNT162b2
- Pipeline Vaccines
  - CVnCoV
  - LUNAR-COV19
  - MRT5500
  - DS-5670
- Non-COVID mRNA Application
  - Immuno-Oncology
  - Cardiology
  - Endocrinology
  - Haematology
  - Other infectious & rare diseases

By End Users

Hospitals & healthcare Clinics
Research Organisation & Institutions
Others

By Region

North America
South America
Europe
Asia-Pacific
Middle East & Africa

Access Full Report [Include Description + TOC] - https://www.marknteladvisors.com/research-library/global-mrna-vaccines-and-therapeutics-market.html

Leading Players Analysis: MRNA Vaccines and Therapeutics Market

The report provides detailed analysis of key players in the global mRNA Vaccines and Therapeutics market, highlighting their strategies and competitive scenario.

Arcturus Therapeutics Holdings Inc.
BioNTech
CureVac N.V.
ethris GmbH
Gennova Biopharmaceuticals Ltd
GlaxoSmithKline plc
Moderna
Pantherna Therapeutics GmbH
Pfizer
Providence Therapeutics
Providence Therapeutics
Silence Therapeutics
Translate Bio
Versameb AG
Verve Therapeutics, Inc.

Note: Should you require specific information beyond the current scope of the report, we are prepared to furnish it as part of our customization services.

For Customized Report Inquiry: - https://www.marknteladvisors.com/query/request-customization/global-mrna-vaccines-and-therapeutics-market.html

Key Benefits for Stakeholders:

Informed Decision-Making: Access to comprehensive and insightful market research reports enables stakeholders to make well-informed decisions, leading to more strategic and successful initiatives.
Strategic Planning: The strategic reports provided by MarkNtel Advisors empower stakeholders to formulate robust strategies for market entry, product development, and competitive positioning.
Market Sizing & Forecasting: Stakeholders can benefit from accurate market sizing and forecasting data to make informed investment and resource allocation decisions, minimizing risks and maximizing returns.
Competitive Benchmarking: The availability of competitive benchmarking data allows stakeholders to assess their performance against industry peers, identify areas for improvement, and capitalize on strengths.
Identifying Investment Opportunities: Through trend analysis and industry insights, stakeholders can identify attractive investment opportunities and stay ahead in the market for better ROI.

About us

MarkNtel Advisors is a leading consulting, data analytics, and market research firm that provides an extensive range of strategic reports on diverse industry verticals. We being a qualitative & quantitative research company, strive to deliver data to a substantial & varied client base, including multinational corporations, financial institutions, governments, and individuals, among others.

We have our existence across the market for many years and have conducted multi-industry research across 80+ countries, spreading our reach across numerous regions like America, Asia-Pacific, Europe, the Middle East & Africa, etc., and many countries across the regional scale, namely, the US, Saudi Arabia, the Netherlands, Saudi Arabia, the UAE, Brazil, and several others.

Contact Information: